Antigen that is taken up via CD205 enters the MHC I and MHC II antigen presentation pathways, and thus an increase in CD205 expression enhances antigen presentation by DCs to both CD8+ cytotoxic T-cells and CD4+ helper T-cells and could potentially lead to long-lived immunity by specifically targeting the cancer cells. The gene discussed is CD8A; the disease is cancer.